method for disease treatment

An amino acid and sequence technology, applied in bone diseases, nervous system diseases, respiratory system diseases, etc., can solve problems such as reducing morbidity and mortality, and missing pathophysiological mechanisms.

Active Publication Date: 2021-09-17
SERPIN PHARMA
View PDF33 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these interventions each provide increased benefit and significantly reduce morbidity and mortality, the incidence of heart failure continues to increase after STEMI, suggesting that one or more key pathophysiological mechanisms are still missing from current treatment paradigms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • method for disease treatment
  • method for disease treatment
  • method for disease treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0338] Example 1 - Treatment of Acute Myocardial Infarction Using SP163M Peptide

[0339] The SP16 peptide is a short fragment derived from the circulating serum protein alpha-1-antitrypsin (AAT). The US FDA has approved the use of three α1-antitrypsin products derived from human plasma: Prolastin, Zemaira, and Aralast.

[0340] As described herein, the SP163M peptide contains the reported anti-inflammatory properties of the parent AAT. In pilot clinical studies conducted at Virginia Commonwealth University (VCU), AAT has been initially shown to safely and effectively block the inflammatory response that occurs after AMI. Furthermore, SP163M has shown equal or better anti-inflammatory activity in preclinical models of AMI. Working with researchers at VCU, we rapidly developed SP16 for the treatment of AMI, a major unmet medical need in the United States and worldwide.

[0341] Acute myocardial infarction (AMI) remains a leading cause of morbidity and mortality in the United...

Embodiment 2

[0387] Met was replaced by Nle to improve peptide stability, for example in SEQ ID NO: 57-Ac-Val-Lys-Phe-Asn-Lys-Pro-Phe-Val-Phe-Leu-Nle-Ile-Glu-Gln-Asn- In the peptide of Thr-Lys-NH2 (SEQ ID NO: 57). Oxidizable methionine.

Embodiment 3

[0388] Example 3 - LRP1 mediates SP16-induced cardioprotection

[0389] SP163M was demonstrated herein to bind LRP1 (low density lipoprotein receptor-related protein) and to be an agonist of LRP1 (as shown for parent AAT). It was also shown that blocking LRP1 abolishes the cardioprotective effects of SP163M and AAT.

[0390] introduce

[0391] LRP1 is the receptor responsible for the plasma clearance of SEC (serine protease inhibitory protease complex accumulated during inflammatory responses). Therefore, the role of LRP1 is to prevent and interrupt inflammation. LRP1 may act via direct regulation of key inflammatory pathways; such as NFkB, IRF-3 and AP-1 (eg ERK p42 / p44, p38 and JNK).

[0392] In murine peritoneal macrophages, LRP1 downregulates LPS-driven inflammatory responses through intracellular interaction with IRF-3. In addition, LRP1 regulates inflammatory cytokines, affects phagocytosis and cell migration, and Treg distribution. Serpins, including peptides such ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Peptides and their use for the treatment of eg acute myocardial infarction and other conditions associated with cytokine storms are described.

Description

[0001] This application is a divisional application of the Chinese patent application with application number 201680063220.6. The filing date of the parent application is August 26, 2016, and the title of the invention is "Method for treating diseases". [0002] Cross References to Related Applications [0003] This application claims priority under 35 U.S.C. §119(e) to Provisional Patent Application Serial No. 62 / 211,296, filed August 28, 2015, the contents of which are incorporated herein by reference in their entirety. [0004] sequence listing [0005] This application contains a Sequence Listing, which has been submitted via EFS-Web in ASCII format, and is hereby incorporated by reference in its entirety. Said ASCII copy, created on December 31, 2012, is named 65292741.txt and is 18,884 bytes in size. [0006] field of invention [0007] The present disclosure provides novel methods of treating diseases including acute myocardial infarction (AMI); gout; ischemia; stroke;...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/81C07K19/00A61K38/55A61K47/60A61P9/10A61P25/00A61P19/06
CPCA61P9/10A61K38/55A61K47/60A61K9/0053A61P19/06A61P9/00A61P25/00A61P11/00A61P31/04A61P31/16A61P29/00A61P31/20A61P31/14
Inventor C·格伯
Owner SERPIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap